APA (7th ed.) Citation

Schmitt, N., Jann, J., Altrock, E., Flach, J., Danner, J., Uhlig, S., . . . Nowak, D. (2022). Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromes. Leukemia, 36(1), . https://doi.org/10.1038/s41375-021-01327-w

Chicago Style (17th ed.) Citation

Schmitt, Nanni, et al. "Preclinical Evaluation of Eltrombopag in a PDX Model of Myelodysplastic Syndromes." Leukemia 36, no. 1 (2022). https://doi.org/10.1038/s41375-021-01327-w.

MLA (9th ed.) Citation

Schmitt, Nanni, et al. "Preclinical Evaluation of Eltrombopag in a PDX Model of Myelodysplastic Syndromes." Leukemia, vol. 36, no. 1, 2022, https://doi.org/10.1038/s41375-021-01327-w.